81 related articles for article (PubMed ID: 20875366)
1. The tumor marker CA-125 and heart failure.
Miñana G; Palau P; Núñez J; Sanchis J
Rev Esp Cardiol; 2010 Oct; 63(10):1213-4. PubMed ID: 20875366
[No Abstract] [Full Text] [Related]
2. [Increased carcinoembryonal antigen--a marker not only for ovarian cancer but also for heart failure].
Dixen U; Hassager C
Ugeskr Laeger; 2004 Nov; 166(48):4381-2. PubMed ID: 15587635
[No Abstract] [Full Text] [Related]
3. Tumour markers in chronic heart failure. Review of the literature and clinical implications.
Faggiano P; D'Aloia A; Antonini-Canterin F; Vizzardi E; Nicolosi GL; Cas LD
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):573-9. PubMed ID: 16858234
[TBL] [Abstract][Full Text] [Related]
4. Relationship between cytokines and tumour markers in patients with chronic heart failure.
Kosar F; Aksoy Y; Ozguntekin G; Ozerol I; Varol E
Eur J Heart Fail; 2006 May; 8(3):270-4. PubMed ID: 16309955
[TBL] [Abstract][Full Text] [Related]
5. Antigen carbohydrate 125 in heart failure: not just a surrogate for serosal effusions?
Núñez J; Miñana G; González M; Garcia-Ramón R; Sanchis J; Bodí V; Núñez E; Chorro FJ; Llàcer A; Miguel A
Int J Cardiol; 2011 Feb; 146(3):473-4. PubMed ID: 21193243
[No Abstract] [Full Text] [Related]
6. Tumour biomarkers in heart failure: is there a role for CA-125?
Yilmaz MB; Nikolaou M; Cohen Solal A
Eur J Heart Fail; 2011 Jun; 13(6):579-83. PubMed ID: 21525015
[TBL] [Abstract][Full Text] [Related]
7. CA125 and immunoinflammatory activity in acute heart failure.
Miñana G; Núñez J; Sanchis J; Bodí V; Núñez E; Llàcer A
Int J Cardiol; 2010 Dec; 145(3):547-8. PubMed ID: 20483181
[No Abstract] [Full Text] [Related]
8. Serum carbohydrate antigen 125 has prognostic significance in heart failure, but no implications on treatment.
Beton O; Yucel O
Int J Cardiol; 2011 Sep; 151(2):241. PubMed ID: 21724271
[No Abstract] [Full Text] [Related]
9. One biologic marker (carbohydrate antigen-CA 125), two different diseases (ovarian cancer and congestive heart failure): practical implications of monitoring CA 125 serum levels. A case report.
Faggiano P; D'Aloia A; Bignotti T; Dei Cas L
Ital Heart J; 2003 Jul; 4(7):497-9. PubMed ID: 14558304
[TBL] [Abstract][Full Text] [Related]
10. [CA-125 - does this next biomarker have a chance to hope for an expectation of risk stratification in patients with heart failure?].
Zieliński T
Kardiol Pol; 2010 Jul; 68(7):779-80. PubMed ID: 20648435
[No Abstract] [Full Text] [Related]
11. CA-125 and heart failure: déjà vu or "still to be seen".
Topatan B; Basaran A
Int J Cardiol; 2010 Dec; 145(3):626-9. PubMed ID: 21035210
[No Abstract] [Full Text] [Related]
12. Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.
Tsavaris N; Mavragani CP; Pikazis D
Ann Rheum Dis; 2007 Jul; 66(7):980. PubMed ID: 17576786
[No Abstract] [Full Text] [Related]
13. Estimation of CA 125 concentration in patients with congestive heart failure.
Skórzyńska H; Solski J; Gernand W; Matras P; Gniwek M; Sokół M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):261-4. PubMed ID: 16145993
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation.
Nägele H; Bahlo M; Klapdor R; Rödiger W
Anticancer Res; 1999; 19(4A):2531-4. PubMed ID: 10470189
[TBL] [Abstract][Full Text] [Related]
15. Tumour marker levels in patients with chronic heart failure.
Varol E; Ozaydin M; Dogan A; Kosar F
Eur J Heart Fail; 2005 Aug; 7(5):840-3. PubMed ID: 15916923
[TBL] [Abstract][Full Text] [Related]
16. [Tumor marker in ovarian cancer].
Komai K; Nishida T
Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
[TBL] [Abstract][Full Text] [Related]
17. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
[TBL] [Abstract][Full Text] [Related]
18. CA-125 and heart failure: Déjà vu continues.
Topatan B; Basaran A
Int J Cardiol; 2011 Mar; 147(2):344-5. PubMed ID: 21255852
[No Abstract] [Full Text] [Related]
19. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
[TBL] [Abstract][Full Text] [Related]
20. [Increased level of carcinoembryonal antigen is not primarily a marker for ovarian cancer].
Kristensen CA; Roed HM
Ugeskr Laeger; 2005 Jan; 167(2):189; author reply 190. PubMed ID: 15697136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
